Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0440
+0.0010 (2.33%)
Jun 17, 2026, 11:57 AM AEST
Market Cap20.52M -20.3%
Revenue (ttm)13.84M +31.4%
Net Income769.30K
EPS0.00
Shares Out 477.12M
PE Ratio26.43
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume313,105
Open0.0420
Previous Close0.0430
Day's Range0.0420 - 0.0440
52-Week Range0.0330 - 0.0590
Beta1.11
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-bas... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements